Navigation Links
Bernstein Liebhard LLP Notes Plaintiffs’ Opposition to Defense Motion in Federal Litigation of DePuy Pinnacle Lawsuit Claims
Date:6/24/2013

(PRWEB) June 24, 2013

Plaintiffs involved with federally-filed DePuy Pinnacle lawsuit claims are engaged in motion practice regarding expert testimony they argue is crucial to the lawsuits pending in the DePuy Pinnacle MDL, Bernstein Liebhard LLP reports.

According to court documents, the issue hinges on whether a particular expert will be able to testify at trial. Plaintiffs in DePuy Pinnacle lawsuits filed in the federal litigation established in the U.S. District Court, Northern District of Texas allege the all-metal version of the DePuy Pinnacle Hip Replacement System, which includes an Ultamet liner, caused them to suffer metallosis and other painful complications indicating early hip failure. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)

“We are pleased to see DePuy Pinnacle hip replacement lawsuits moving forward in the federal litigation as we continue to hear from patients who allegedly experienced metallosis and other complications stemming from the all-metal version of the Pinnacle hip replacement,” says Bernstein Liebhard LLP, a nationwide law firm representing individuals affected by defective drugs and medical devices. The Firm is actively filing lawsuits in the federal litigation on behalf of patients allegedly injured by the artificial hip. Additionally, Bernstein Liebhard LLP partner, Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee in the litigation.

DePuy Pinnacle Lawsuit Claims

According to a Master Case List update issued by the Northern District of Texas on June 3rd, 2013, 4,246 DePuy Pinnacle lawsuit claims had been filed in the federal proceeding. These claims were filed by patients allegedly injured by the all-metal version of the Pinnacle hip. Complications associated with this device are allegedly caused by its potential to wear out, which in turn may cause metallic debris to shed into the patient’s blood stream.

Less than a month before this Case List update was posted, Johnson & Johnson announced its plans to halt sales of the all-metal version of the DePuy Pinnacle hip replacement, as well as other metal-on-metal hip devices currently manufactured by DePuy Orthopaedics. The company’s decision to end sales of its metal-on-metal hip replacements was published in a May 16th report from the New York Times.* In citing its reasons for stopping sales of these devices, the company stressed that its decision did not signify a DePuy Pinnacle recall and was prompted by lower sales demands, as well as the U.S. Food and Drug Administration (FDA)’s recent proposal to institute new regulations for approving metal hip implants.

According to the new regulations proposed by the agency in January 2013, all manufacturers of this class of devices would be required to conduct safety and efficacy studies on their products in order to continue selling them. Thus, metal-on-metal hip replacements would become ineligible to receive approval via the FDA’s 510(k) process, which allows a device to bypass human testing.**

Patients who allegedly experienced complications stemming from the all-metal version of the DePuy Pinnacle Hip Replacement System may be entitled to compensation for medical bills, pain and suffering and other damages caused by their injuries. Visit Bernstein Liebhard LLP’s website to learn more about how to file a lawsuit over the implant you received or call a DePuy Pinnacle lawyer directly at 800-511-5092 today.

*nytimes.com/2013/05/17/business/jj-is-phasing-out-metal-replacement-hips.html?ref=health&_r=0
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/depuy-pinnacle-lawsuit/depuy-pinnacle-recall/prweb10864866.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
2. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
3. Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports
4. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
5. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
6. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
7. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
8. DePuy ASR Hip Recall, Transvaginal Mesh Lawsuit Updates: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trials in New Year
9. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
10. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
11. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: